Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 21.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares traded hands during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.07. The company has a market capitalization of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Canadian Penny Stocks: Can They Make You Rich?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- There Are Different Types of Stock To Invest In
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Makes a Stock a Good Dividend Stock?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
